Patents by Inventor Piyush KANSAGRA

Piyush KANSAGRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stable extended release pharmaceutical composition of clozapine
    Patent number: 11918590
    Abstract: Disclosed are stable extended release formulations and pharmaceutical compositions of Clozapine that exhibit improved stability under a variety of conditions, as well as processes for the preparation of such formulations and compositions.
    Type: Grant
    Filed: April 8, 2022
    Date of Patent: March 5, 2024
    Assignee: Intas Pharmaceuticals Ltd.
    Inventors: Rikin Patel, Kavan Pandya, Piyush Kansagra, Satyavan Dhavale, Ashish Sehgal
  • Extended release pharmaceutical composition of Clozapine
    Patent number: 11833253
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: December 5, 2023
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Mayank Saxena, Rikin Patel, Piyush Kansagra, Balvir Singh, Ashish Sehgal
  • STABLE EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF CLOZAPINE
    Publication number: 20230181595
    Abstract: Disclosed are stable extended release formulations and pharmaceutical compositions of Clozapine that exhibit improved stability under a variety of conditions, as well as processes for the preparation of such formulations and compositions.
    Type: Application
    Filed: April 8, 2022
    Publication date: June 15, 2023
    Inventors: Rikin Patel, Kavan Pandya, Piyush Kansagra, Satyavan Dhavale, Ashish Sehgal
  • Extended release pharmaceutical composition of Clozapine
    Patent number: 11648207
    Abstract: Disclosed is an extended release pharmaceutical composition of Clozapine, which can be provided as a reservoir type dosage form, and when dosed to a patient once daily achieves at steady state, AUC0-24h, Cmax and Cmin in patient plasma that are within 80 to 125% bioequivalence criteria compared to immediate release Clozapine dosed at the same total daily dose divided twice per day. Further, the pharmaceutical composition of Clozapine can provide once daily dosing regimen in order to improve patient compliance and reduces side effects in patients in need thereof. The pharmaceutical composition further lacks any significant food effect on oral administration.
    Type: Grant
    Filed: April 8, 2022
    Date of Patent: May 16, 2023
    Inventors: Rikin Patel, Kavan Pandya, Piyush Kansagra, Satyavan Dhavale, Ashish Sehgal
  • Extended release pharmaceutical composition of clozapine
    Patent number: 11504336
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Grant
    Filed: September 16, 2017
    Date of Patent: November 22, 2022
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Mayank Saxena, Rikin Patel, Piyush Kansagra, Balvir Singh, Ashish Sehgal
  • EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF CLOZAPINE
    Publication number: 20200054573
    Abstract: An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.
    Type: Application
    Filed: September 16, 2017
    Publication date: February 20, 2020
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Mayank SAXENA, Rikin PATEL, Piyush KANSAGRA, Balvir SINGH, Ashish SEHGAL